Learn more about investing in Microgenesis

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Microgenesis
Microgenesis
A new fertility test and treatment for women everywhere
CONTACT COMPANY
INVESTOR INQUIRIES
Diagnostics Human Health Medtech Women's Health IBSF10 2020 Seed Female Founders Human Health 100 Argentina United States
* Data source: Crunchbase
Founded
2019
Employees*
2-10
Funding to Date*
$200K
Website
microgenesis.net
* Data source: Crunchbase
Gabriela Guiterrez, Ph.D., CEO
At Microgenesis, we detangle age from inflammation.
Infertility affects 15% of all couples.

Microgenesis offers a new fertility test and treatment that restores the fertility potential of women everywhere with a three-month, drug-free treatment. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Microgenesis has proven their validity on the toughest cases: women who have already failed multiple IVF implantations.

Team
Leandro Barreiro
Co-Founder
Agustina Azpiroz
Co-Founder
Gabriela Gutierrez
CEO
Company News
The Manila Times | December 28, 2022
Microgenesis receives 2022 Microsoft PH Partner Award | The Manila Times

MICROSOFT Philippines recently hosted its 2022 Partner Awards, recognizing partners for their outstanding, innovative efforts to positively impact stakeholders every year. This…
TechCrunch | October 27, 2020
Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day

Biotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For IndieBio, a science and biotech accelerator run by VC firm SOSV, this unprecedented year offered high …